Format

Send to

Choose Destination
J Clin Invest. 2012 Oct;122(10):3407-15. doi: 10.1172/JCI61203. Epub 2012 Oct 1.

Molecular genetics of B-precursor acute lymphoblastic leukemia.

Author information

1
Department of Pathology, St. Jude Children’s Research Hospital, Memphis, Tennessee 38105, USA. charles.mullighan@stjude.org

Abstract

B-precursor acute lymphoblastic leukemia (B-ALL) is the most common childhood tumor and the leading cause of cancer-related death in children and young adults. The majority of B-ALL cases are aneuploid or harbor recurring structural chromosomal rearrangements that are important initiating events in leukemogenesis but are insufficient to explain the biology and heterogeneity of disease. Recent studies have used microarrays and sequencing to comprehensively identify all somatic genetic alterations in acute lymphoblastic leukemia (ALL). These studies have identified cryptic or submicroscopic genetic alterations that define new ALL subtypes, cooperate with known chromosomal rearrangements, and influence prognosis. This article reviews these advances, discusses results from ongoing second-generation sequencing studies of ALL, and highlights challenges and opportunities for future genetic profiling approaches.

PMID:
23023711
PMCID:
PMC3461902
DOI:
10.1172/JCI61203
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for American Society for Clinical Investigation Icon for PubMed Central
Loading ...
Support Center